Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Randy912
    Junior Member
    • Aug 2016
    • 2

    #1

    RankProduct - Is this a valid analysis?

    Hello,

    I analyzed a few GEO data sets that were on different microarray platforms using the RankProd R library.

    However, since the data sets were on different microarray platforms, they have different probe sets and hence there were tons of NAs in the all-inclusive expression set. The candidates I ended up taking from this analysis actually ended up working, but I'm wondering if this analysis is defensible.

    Thank you in advance for any insight
  • IonTom
    Member
    • Apr 2014
    • 32

    #2
    From my experience Rank Product test gives much better and reliable results than most parametric methods.

    To your question. You should limit both microarrays to the probes that are available on both platforms. Otherwise the number of probes will be different for both platforms and the ranks will not be comparable.

    But limiting the probe sets should help. If the probes are nor directly matchable,
    you could use the gene level expression for a comparison.

    Comment

    • Randy912
      Junior Member
      • Aug 2016
      • 2

      #3
      The microarray platforms have totally different probe annotations, so there are actually 0 probe sets shared across all platforms.

      When you say "use gene level expression," how do you change the probe set names to facilitate the matches? For example, let's say gene X has probes 38548_at in an affy array, and 294838 in an Illumina array, how do you modify them so that the comparison can be made?

      Thank you for your help.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:05 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Working...